Business Wire

Nordic Enterprises See SDN as Key to Network Agility, Working from Home

Share

Enterprises in the Nordics are expanding their adoption of software-defined networking technology to become more agile and flexible while enabling employees to more easily work from home, according to a new report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm.

The 2021 ISG Provider LensNetwork – Software Defined Solutions and Services Report for the Nordics finds enterprises in the region looking to SDN-related technologies and service providers to help them with challenges related to the flexibility, speed and collaboration they need to better serve their employees and their increasingly mobile customers.

“Nordic enterprises are looking to SDN and its service providers to increase their network agility, flexibility and competitiveness while enabling remote working and better business continuity,” said Jan Erik Aase, partner and global leader, ISG Provider Lens Research. “This new need for enterprise agility goes beyond the abilities of traditional networks in a constantly changing competitive environment.”

The report also sees enterprises in the region embracing SD-WAN to enable remote working. While WAN architecture at enterprises has created backhaul challenges, that architecture is evolving to support more connectivity choices. Vendors are enabling enterprises to use a variety of transport options actively or on standby.

In addition, Nordic enterprises are moving toward more automation and analytics. Enterprises are increasingly embracing the concept of the network as code, where changes in the network infrastructure can be handled through code changes. Service providers are leveraging automation tools and allowing visibility into the cloud, the data center, and the WAN. Nordic enterprises see SD-WAN as a way to drive automation, reduce reliance on network hardware and consolidate network functionality.

Nordic enterprises are also seeking end-to-end connectivity to analyze data at the edge, including data generated by Internet of Things (IoT) devices, the report says. Service providers and system integrators are exploring ways to bring new capabilities to Wi-Fi 6, long-term evolution (LTE) and fifth-generation (5G) networks. They are also looking to assist customers with large public 5G rollouts, with some spectrum potentially allocated for enterprises.

New SDN-related technologies will pave the way for the industrial IoT to scale up and for edge computing to grow further, the report adds. However, a more inclusive network ecosystem is needed for the cloud, which is evolving into a holistic web of network technologies that include components of SDN such as WAN, LAN and Wi-Fi 6 management.

The report also sees changes in network practices driven in part by the move in the Nordics to the cloud and to the software-as-a-service model. Enterprises there have been seeing more internet-based traffic, which has led them to consider new ways to look at connectivity. Enterprises are moving away from a conventional hub-and-spoke networking model and considering instead an any-to-any connectivity model that supports more cloud-oriented traffic patterns.

The 2021 ISG Provider LensNetwork – Software Defined Solutions and Services Report for the Nordics evaluates the capabilities of 55 providers across six quadrants: Managed (SD) WAN Services, SDN Transformation Services (Consulting and Implementation), SD-WAN Equipment and Service Suppliers (DIY), Technology and Service Suppliers (Core – 4G/5G), Edge Technology and Services, and Enterprise 5G Solutions.

The report names Orange Business Services as a leader in five quadrants and BT, Cisco, Deutsche Telekom, HCL, IBM, Tech Mahindra and Wipro as leaders in four. Ericsson, HPE Aruba and Nuage Networks are named leaders in three quadrants, and Infosys, TCS, Telenor, Telia, Verizon and VMware are named leaders in two. Citrix, Juniper Networks, Nokia Networks and Versa Networks are named leaders in one quadrant.

In addition, Tech Mahindra, Verizon and Wipro were named Rising Stars—companies with “promising portfolios” and “high future potential” by ISG’s definition—in two quadrants. GTT and Infosys were named Rising Stars in one quadrant each.

The 2021 ISG Provider LensNetwork – Software Defined Solutions and Services Report for the Nordics is available to subscribers or for one-time purchase on this webpage.

About ISG Provider Lens™ Research

The ISG Provider Lens™ Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Germany, Switzerland, the U.K., France, the Nordics, Brazil and Australia/New Zealand, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage.

A companion research series, the ISG Provider Lens Archetype reports, offer a first-of-its-kind evaluation of providers from the perspective of specific buyer types.

About ISG

ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 700 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Will Thoretz, ISG
+1 203 517 3119
will.thoretz@isg-one.com

Erik Arvidson, Matter Communications for ISG
+1 617 755 2985
isg@matternow.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

HiddenA line styled icon from Orion Icon Library.Eye